Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$47.97 - $62.21 $6,811 - $8,833
-142 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$54.64 - $61.3 $4,152 - $4,658
76 Added 115.15%
142 $8,000
Q2 2021

Aug 13, 2021

SELL
$59.18 - $69.99 $233,110 - $275,690
-3,939 Reduced 98.35%
66 $4,000
Q2 2021

Aug 13, 2021

BUY
$59.18 - $69.99 $233,110 - $275,690
3,939 Added 5968.18%
4,005 $66,000
Q4 2020

Feb 09, 2021

BUY
$50.47 - $66.26 $100 - $132
2 Added 3.13%
66 $4,000
Q3 2020

Nov 05, 2020

BUY
$51.97 - $63.0 $3,326 - $4,032
64 New
64 $4,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.1B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Liberty Wealth Management LLC Portfolio

Follow Liberty Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty Wealth Management LLC with notifications on news.